
|Videos|May 13, 2013
Treating Patients With Chemotherapy and Biotherapy
Author(s)Monica Fradkin, RN, BSN, MPH, OCN
Monica Fradkin, RN, BSN, MPH, OCN, Oncology Nursing Education Coordinator, Yale School of Nursing, Smilow Cancer Hospital at Yale-New Haven, discusses treating patients with chemotherapy and biotherapy.
Advertisement
Monica Fradkin, RN, BSN, MPH, OCN, Oncology Nursing Education Coordinator, Yale School of Nursing, Smilow Cancer Hospital at Yale-New Haven, discusses treating patients with chemotherapy and biotherapy.
Clinical Pearls
Biotherapies are very targeted, Fradkin says, targeting one specific cell type or gene. All biotherapies are often grouped together as hazardous, even though they may not all be. Safety measures still need to be taken to keep patients safe.
- Biotherapy is very targeted, looking at one specific cell type or gene
- Biotherapies are categorized together as hazardous drugs, when they may not all be
- Safety measures need to be kept in place in order to keep patients safe
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Priority Review to Gedatolisib for Advanced Breast Cancer
2
RFS Benefit Sustained at 5 Years for Intismeran Autogene in Melanoma
3
Epcoritamab Monotherapy Yields Positive Results in Phase 3 R/R DLBCL Trial
4
FDA Grants BTD to Sofetabart Mipitecan for Platinum-Resistant Ovarian Cancer
5













































